Overview

The global Diagnostic Medical Imaging Market was valued at USD 45.2 billion in 2025 and is projected to reach USD 79.5 billion by 2034, growing at a CAGR of 6.4% during the forecast period (2026-2034). The market is driven by the rising global burden of cancer and cardiovascular disease, expanding national screening programs, and accelerating replacement of aging radiology equipment with artificial-intelligence-enabled scanners that shorten examination times and improve diagnostic confidence. The market is shifting from conventional, standalone, hardware-centric imaging systems toward connected, software-defined platforms in which artificial intelligence supports protocol selection, image reconstruction, automated measurement, and triage of urgent findings. Government initiatives such as the European Union's Medical Device Regulation (EU) 2017/745, which requires stricter clinical evaluation and post-market surveillance for imaging systems sold across the European Economic Area, and India's Production-Linked Incentive Scheme for medical devices, administered by India's Department of Pharmaceuticals, are shaping compliance costs while encouraging domestic manufacturing capacity for imaging equipment and components. By region, North America held the dominant share of the market in 2025, supported by extensive installed imaging capacity, comprehensive insurance reimbursement, and early adoption of AI-enabled platforms. Asia-Pacific is expected to register the fastest growth through 2034 as hospital construction, rising insurance penetration, and expanding domestic manufacturing in China, India, Japan, and South Korea widen patient access to advanced imaging services.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Artificial Intelligence-Enabled Workflow Automation and Photon-Counting CT Adoption Emerging as a Transformational Trend

• Radiology departments worldwide are integrating artificial intelligence tools across the complete imaging pathway, from patient scheduling and protocol selection to image reconstruction and structured reporting. This end-to-end automation is reducing repeat examinations and allowing technologists to manage higher patient volumes without compromising diagnostic accuracy.
• Photon-counting computed tomography detectors are replacing conventional scintillator-based systems by directly converting X-ray photons into electronic signals, delivering sharper spatial resolution and lower radiation dose. Vendors are pairing this hardware advance with deep-learning reconstruction engines that suppress image noise, improving visualization of small vessels, calcifications, and early-stage tumors.
• Academic medical centers and multi-site imaging networks are establishing dedicated simulation and training reference sites so that clinicians become familiar with next-generation scanners ahead of full commercial rollout. This collaborative adoption model is shortening the learning curve for complex modalities and is becoming a competitive differentiator for equipment manufacturers pursuing hospital-system partnerships.
• HKSH Medical Group and Siemens Healthineers established Asia's first Photon-Counting CT Simulator Reference Site in Hong Kong to advance clinician training, clinical research, and precision radiotherapy planning using photon-counting technology. This collaboration can be verified through the Siemens Healthineers newsroom at siemens-healthineers.com.

KEY MARKET DRIVER

Rising Global Burden of Cancer and Cardiovascular Disease Driving Demand for Early and Precise Imaging

• Timely and accurate diagnosis of cancer and cardiovascular conditions depends heavily on high-resolution imaging to guide staging, treatment planning, and monitoring of therapeutic response. As chronic disease prevalence climbs across both developed and emerging economies, healthcare systems are prioritizing capital investment in advanced imaging infrastructure to support earlier clinical intervention.
• National screening programs for breast, lung, and colorectal cancer are expanding across multiple countries, directly increasing the volume of mammography, low-dose CT, and virtual colonoscopy procedures performed each year. This structured screening expansion is creating recurring, predictable demand for imaging equipment replacement and long-term service contracts across hospital and outpatient settings.
• Manufacturers are responding with dose-reduction software, AI-assisted triage tools that flag urgent findings for radiologist review, and cardiac-gated CT protocols that shorten breath-hold times for patients with limited cardiopulmonary reserve. These innovations are lowering barriers to imaging in elderly and high-risk populations, widening the addressable patient base for diagnostic imaging providers.
• The U.S. Preventive Services Task Force reaffirmed its recommendation for biennial mammography screening in women beginning at age forty, a policy position that continues to sustain national breast cancer screening volumes in the United States.

KEY MARKET OPPORTUNITY

Expansion of Point-of-Care Handheld Ultrasound Devices Creating New Growth Avenues

• Handheld ultrasound probes that connect directly to smartphones and tablets are opening imaging access in primary care clinics, ambulances, and rural health posts that previously lacked dedicated radiology infrastructure. This decentralization is creating a purchasing channel that extends well beyond traditional hospital radiology departments.
• Emerging economies with limited numbers of installed CT and MRI systems represent a substantial untapped opportunity for lower-cost, portable imaging platforms that can be deployed without extensive facility modification. Vendors offering flexible financing and subscription-based service models are well positioned to capture first-time institutional buyers in these markets.
• Subscription-based pricing models for AI image-analysis software are allowing smaller diagnostic centers to access advanced detection capabilities without large upfront capital outlays. This shift is attracting new categories of technology partners and investors into a market that has historically been dominated by capital-intensive hardware sales.
• Mindray launched its expanded Hepatus-series ultrasound systems, including a dedicated liver-imaging platform that integrates quantitative elastography with diagnostic ultrasound, broadening point-of-care access to gastroenterology imaging. 

Diagnostic Medical Imaging Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Modality

X-ray imaging systems held the largest share of the diagnostic medical imaging market in 2025 because of their low per-scan cost, rapid throughput, and continued relevance in emergency medicine, orthopedics, dental care, and routine chest and skeletal examinations. Digital radiography has replaced analog film across most developed markets, and flat-panel detector upgrades have shortened acquisition times while lowering radiation exposure. X-ray units remain the first imaging modality installed in newly built clinics and rural health centers because they require comparatively modest capital investment and simpler operator training than cross-sectional modalities such as CT or MRI, reinforcing their broad global installed base across hospitals of every size.

Computed tomography scanners are projected to grow at the fastest CAGR during the forecast period because of accelerating demand for photon-counting detector systems that deliver sharper spatial resolution, reduced radiation dose, and improved tissue characterization compared with conventional CT. Expanding applications in cardiac calcium scoring, lung cancer screening, and trauma triage are pushing hospitals to replace aging systems with higher-slice, AI-enabled platforms capable of faster patient throughput. Regulatory clearances for next-generation spectral and photon-counting CT systems across major markets are accelerating clinical adoption, while academic centers are establishing dedicated reference sites to train radiology staff ahead of broader commercial rollout, further reinforcing the segment's above-market growth trajectory.

Modality categories include

                ·           X-Ray Imaging Systems (Dominating Segment)

                ·           Computed Tomography (CT) Scanners (Highest CAGR Segment)

                ·           Ultrasound Systems

                ·           Magnetic Resonance Imaging (MRI) Systems

                ·           Nuclear Imaging Systems

                ·           Others

Analysis by Portability

Fixed imaging systems accounted for the largest share of the market in 2025, supported by their superior image quality, larger bore and detector sizes, and ability to support the full range of advanced clinical protocols required in tertiary and quaternary care hospitals. Centralized radiology departments continue to invest in fixed CT, MRI, and angiography suites because these installations support high patient throughput, sophisticated service contracts, and integration with picture archiving and communication systems across an entire health network. The high upfront capital cost of fixed systems is offset by their long operational lifespan and their capacity to serve as the diagnostic backbone for cancer centers, trauma units, and interventional radiology suites.

Mobile and handheld imaging systems are expected to expand at the fastest rate during the forecast period as point-of-care ultrasound and portable X-ray units gain traction in intensive care units, ambulances, and community health settings. Wireless probes that pair with tablets and smartphones are lowering the cost of entry for primary care physicians and emergency responders who previously had no direct access to bedside imaging. Growing government emphasis on strengthening rural and community healthcare infrastructure, combined with the compact form factor and battery-powered operation of these devices, is enabling rapid deployment in settings that lack dedicated radiology suites, positioning portable systems as the fastest-expanding portability category.

Portability categories include

                ·           Fixed Systems (Dominating Segment)

                ·           Mobile and Handheld Systems (Highest CAGR Segment)

Analysis by Application

Oncology imaging held the largest application share of the market in 2025 because cancer diagnosis, staging, treatment planning, and post-treatment surveillance all depend heavily on repeated cross-sectional and molecular imaging studies performed over the course of a patient's care journey. National cancer screening programs covering breast, lung, cervical, and colorectal cancer are driving sustained demand for mammography, low-dose CT, and PET-CT procedures across both developed and emerging healthcare systems. The rising global cancer incidence associated with aging populations, combined with expanding access to targeted radiotherapy planning that requires precise anatomical imaging beforehand, continues to reinforce oncology's position as the leading clinical application for diagnostic imaging equipment worldwide.

Cardiology imaging is projected to grow at the fastest CAGR during the forecast period, supported by rising global prevalence of coronary artery disease, heart failure, and structural heart conditions that require detailed, non-invasive visualization for diagnosis and procedural planning. Advances in cardiac CT angiography, including coronary calcium scoring and fractional flow reserve analysis derived directly from CT images, are reducing reliance on invasive catheterization for many patients. Growing adoption of cardiac MRI for tissue characterization in cardiomyopathy cases, together with expanding structural heart procedures that depend on precise pre-procedural imaging, is accelerating equipment demand within the cardiology application segment.

Application categories include

                ·           Oncology (Dominating Segment)

                ·           Cardiology (Highest CAGR Segment)

                ·           Neurology

                ·           Orthopedics

                ·           Gastroenterology

                ·           Gynecology and Obstetrics

                ·           Others

Analysis by End User

Hospitals represented the largest end-user segment of the diagnostic medical imaging market in 2025, supported by their comprehensive service offerings, centralized patient care model, and financial capacity to fund high-cost imaging technologies such as MRI, PET-CT, and interventional angiography suites. Hospitals frequently serve as referral centers for complex cases that require the full range of imaging modalities under a single roof, along with continuous radiology coverage for emergency and trauma cases. Their scale also allows hospitals to negotiate long-term equipment service and upgrade contracts with manufacturers, further cementing their role as the primary purchaser of advanced diagnostic imaging systems across both public and private healthcare networks.

Standalone diagnostic imaging centers are expected to grow at the fastest rate among end users during the forecast period, reflecting a broader shift of routine and outpatient imaging away from hospital settings toward lower-cost, appointment-based facilities. These centers benefit from streamlined operations and extended operating hours, making them attractive to insurers and self-pay patients seeking faster access to scans than hospital-based imaging departments typically provide. The growing prevalence of multi-site imaging networks that operate dozens of centers under shared radiology and administrative platforms is enabling rapid geographic expansion, positioning freestanding imaging centers as the fastest-expanding end-user category.

End User categories include

                ·           Hospitals (Dominating Segment)

                ·           Diagnostic Imaging Centers (Highest CAGR Segment)

                ·           Specialty Clinics

                ·           Others

By Region

Diagnostic Medical Imaging Market Regional Analysis

Diagnostic Medical Imaging Market Share, 2025 and 2034 (CAGR)

North America

38%

South America

XX%

Europe

XX%

Middle East Africa

XX%

Asia Pacific

28%

Regional Analysis

North America held the largest regional share of the diagnostic medical imaging market in 2025, supported by extensive CT and MRI installed capacity, comprehensive reimbursement coverage under both public and private insurance programs, and early adoption of AI-enabled imaging platforms across major hospital systems. The region benefits from a concentration of leading equipment manufacturers headquartered domestically, established regulatory clearance pathways through the Food and Drug Administration, and a well-developed network of freestanding diagnostic imaging centers. The Centers for Medicare and Medicaid Services' reimbursement policies directly influence equipment purchasing cycles, while manufacturers are expanding domestic production of CT and MRI systems to reduce exposure to cross-border component tariffs. Competitive intensity remains high among established original equipment manufacturers and a growing number of AI software vendors competing for hospital-system partnerships, with continued replacement of aging equipment expected to sustain the region's leadership position through the forecast period.

Asia-Pacific is projected to be the fastest-growing region during the forecast period, advancing on the strength of large-scale hospital construction programs in China and India, Japan's aging population driving replacement demand for advanced modalities, and South Korea's strong domestic ultrasound and MRI manufacturing base. China's centralized volume-based procurement policy for medical equipment is reshaping vendor pricing strategies, while India's public health insurance schemes are expanding patient access to diagnostic imaging in smaller cities. Regulatory reforms, including streamlined approval pathways through China's National Medical Products Administration and Japan's Pharmaceuticals and Medical Devices Agency, are shortening time-to-market for new imaging systems. Domestic manufacturers such as regional CT, MRI, and ultrasound producers are competing aggressively against multinational original equipment manufacturers on price and localized service networks, intensifying competition across both premium and value-tier imaging equipment segments in the region.

Countries and Regions Covered

North America (Dominating Region)

o    United States (Largest Country Market)

o    Canada

o    Mexico

Asia-Pacific (Fastest Growing Region)

o    China (Largest Country Market)

o    India (Fastest-Growing Country Market)

o    Japan

o    South Korea

o    Rest of Asia-Pacific

Europe

o    Germany (Largest Country Market)

o    France

o    United Kingdom

o    Italy

o    Rest of Europe

Latin America

o    Brazil (Largest Country Market)

o    Chile (Fastest-Growing Country Market)

o    Rest of Latin America

Middle East and Africa

o    Saudi Arabia (Largest Country Market)

o    United Arab Emirates (Fastest-Growing Country Market)

o    Rest of Middle East and Africa

Market Share

The diagnostic medical imaging market is consolidated, with a small group of multinational equipment manufacturers commanding the largest share of global revenue through comprehensive modality portfolios, established service networks, and long-standing hospital relationships. Regional manufacturers based in China and South Korea are intensifying competition in the mid-market segment through competitively priced CT, MRI, and ultrasound systems supported by localized service infrastructure. Key success factors include the depth of AI software integration, the breadth of installed base that generates recurring service revenue, and the speed of regulatory clearance across major markets. Leading companies are prioritizing artificial intelligence platform differentiation, photon-counting CT innovation, and expansion of point-of-care and handheld imaging portfolios, while pursuing targeted acquisitions of AI-focused software companies to strengthen image-analysis capabilities and workflow-automation offerings.

Key Players

                       ·           GE HealthCare Technologies Inc. (US)

                       ·           Siemens Healthineers AG (Germany)

                       ·           Koninklijke Philips N.V. (Netherlands)

                       ·           Canon Medical Systems Corporation / Canon Inc. (Japan)

                       ·           FUJIFILM Holdings Corporation (Japan)

                       ·           Shimadzu Corporation (Japan)

                       ·           Hologic, Inc. (US)

                       ·           Samsung Medison Co., Ltd. / Samsung Electronics (South Korea)

                       ·           Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)

                       ·           United Imaging Healthcare Co., Ltd. (China)

                       ·           Carestream Health, Inc. (US)

                       ·           Esaote S.p.A. (Italy)

                       ·           Konica Minolta, Inc. (Japan)

                       ·           Varex Imaging Corporation (US)

                       ·           Agfa-Gevaert Group / Agfa HealthCare (Belgium)

                       ·           Neusoft Medical Systems Co., Ltd. (China)

                       ·           Bracco Imaging S.p.A. (Italy)

                       ·           Butterfly Network, Inc. (US)

                       ·           DeepHealth, Inc. (US)

                       ·           Trivitron Healthcare Pvt. Ltd. (India)

Recent Market Developments

• In July 2025, RadNet, Inc. completed the acquisition of iCAD, Inc. through its wholly owned subsidiary DeepHealth, combining iCAD's ProFound Breast Health Suite with DeepHealth's SmartMammo platform to create a combined AI-powered breast cancer screening portfolio serving more than 1,500 healthcare provider locations across over 50 countries. The combination is expected to accelerate AI adoption in breast cancer screening and expand DeepHealth's global installed base for mammography image interpretation.
• In November 2025, GE HealthCare received CE mark approval in Europe for its Omni total-body PET/CT scanner designed to incorporate diagnostic and theranostic tracers into clinical care and research, alongside CE mark approval for its StarGuide GX 4D SPECT/CT system capable of imaging across a wide range of energy levels for general-purpose nuclear medicine studies.
• In April 2026, Canon Medical Systems advanced clinical research collaboration in Japan involving its Ultimion photon-counting CT system, partnering with the National Cancer Center Hospital East and its Center for Advanced Medical Development to evaluate next-generation CT imaging applications in oncology.
• In April 2026, Koninklijke Philips N.V. received U.S. FDA 510(k) clearance for its Spectral CT Verida system, which combines a third-generation dual-layer detector with AI-based deep learning reconstruction to reduce image noise and enhance CT image quality across radiology, cardiology, and oncology applications.

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What is Diagnostic Medical Imaging?

2

What is the CAGR of the Diagnostic Medical Imaging Market?

3

Which modality leads the Diagnostic Medical Imaging Market?

4

Which application dominates the Diagnostic Medical Imaging Market?

5

Which end user segment has the highest market share?

6

What are the latest trends in the Diagnostic Medical Imaging Market?

7

Who are the end users of Diagnostic Medical Imaging equipment?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates